Hyperkalemia Evident with Spironolactone in Resistant HTNHyperkalemia Evident with Spironolactone in Resistant HTN
A small study finds that 8% of resistant-hypertension patients treated with spironolactone developed hyperkalemia, including one who presented to the emergency department. Researchers advise doctors to monitor potassium levels when using the drug. Heartwire
Source: Medscape Nephrology Headlines - Category: Urology & Nephrology Tags: Cardiology News Source Type: news
More News: Cardiology | Emergency Medicine | Heart | Hypertension | Spironolactone | Study | Urology & Nephrology